摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2-苄氧基苯基)-肼盐酸盐 | 34288-06-7

中文名称
(2-苄氧基苯基)-肼盐酸盐
中文别名
——
英文名称
2-benzyloxyphenylhydrazine hydrochloride
英文别名
——
(2-苄氧基苯基)-肼盐酸盐化学式
CAS
34288-06-7
化学式
C13H14N2O*ClH
mdl
——
分子量
250.728
InChiKey
KZRIXZCUNKWRDF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    136-138 °C

计算性质

  • 辛醇/水分配系数(LogP):
    2.97
  • 重原子数:
    17.0
  • 可旋转键数:
    4.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    47.28
  • 氢给体数:
    2.0
  • 氢受体数:
    3.0

安全信息

  • 海关编码:
    2928000090

SDS

SDS:1401f5b484f0e198eb3e9acffd30b521
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: (2-Benzyloxy-phenyl)-hydrazine, HCl
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: (2-Benzyloxy-phenyl)-hydrazine, HCl
CAS number: 34288-06-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C13H14N2O.ClH
Molecular weight: 250.7

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    (2-苄氧基苯基)-肼盐酸盐 甲酸铵 、 sodium hydride 、 caesium carbonate溶剂黄146 、 zinc(II) chloride 作用下, 以 乙醇乙酸乙酯N,N-二甲基甲酰胺丙酮 为溶剂, 反应 25.17h, 生成 N-[3-(4-methoxymethoxy-phenyl)-1-methyl-propyl]-2-[2-phenyl-7-(2-piperidin-1-yl-ethoxy)-1H-indol-3-yl]-acetamide
    参考文献:
    名称:
    Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERα
    摘要:
    A novel class of indole ligands for estrogen receptor alpha have been discovered which exhibit potent affinity and high selectivity. Substitution of the bazedoxifene skeleton to the linker present in the HTS lead 1a provided 22b which was found to be 130-fold alpha-selective and acted as an antagonist of estradiol activity in uterine tissue and MCF-7 cancer cells.
    DOI:
    10.1016/j.bmcl.2007.01.054
  • 作为产物:
    描述:
    2-苄氧基苯胺盐酸 、 sodium nitrite 、 tin(ll) chloride 作用下, 以 为溶剂, 生成 (2-苄氧基苯基)-肼盐酸盐
    参考文献:
    名称:
    谷氨酸衍生物作为抗氧化剂和消炎药的设计,合成及生物学评价
    摘要:
    合成了一系列谷氨酸衍生物,并评估了其抗氧化活性和稳定性。我们发现了几种有效且稳定的谷氨酸衍生物。其中,化合物12b显示出良好的体外活性,化学稳定性和细胞毒性。原型化合物12b在LPS刺激的RAW 264.7细胞系和斑马鱼模型中显示出抗炎作用。
    DOI:
    10.1016/j.bmcl.2017.11.012
点击查看最新优质反应信息

文献信息

  • TOPICAL ANTIFUNGAL AGENT
    申请人:Ohyama Makoto
    公开号:US20130317074A1
    公开(公告)日:2013-11-28
    An anti-fungal agent for tinea comprising as active ingredient a compound having the skeleton of 2-(1H-pyrazol-1-yl)phenol represented by the following formula (I) or (II) or a salt thereof is provided
    一种用于治疗癣的抗真菌剂,其活性成分为具有以下化学式(I)或(II)所代表的2-(1H-吡唑-1-基)酚骨架或其盐。
  • PATCH FOR ANTI-DERMATOPHYTOSIS
    申请人:MEIJI SEIKA PHARMA CO., LTD.
    公开号:US20150209301A1
    公开(公告)日:2015-07-30
    A patch for nails or skin for prevention or treatment of dermatophytosis, containing a layer including a pressure sensitive adhesive layer and a compound represented by the formula: wherein R 1 represents hydrogen, C 1-16 alkyl, or trifluoromethyl; R 2 represents hydrogen, C 1-6 alkyl, halogen, —COO(C 1-6 alkyl), or (CH 2 ) 1-3 COOR; R 3 represents hydrogen, C 1-6 alkyl, amino, trifluoromethyl, or OR; R 4 represents hydroxyl; R 5 represents hydrogen, C 1-6 alkyl, hydroxyl, or halogen; R 6 represents hydrogen, C 1-6 alkyl, trifluoromethyl, halogen, amino, —NR a R b , nitro, hydroxy-C 1-6 alkyl, —CONR a R b , —COO(C 1-6 alkyl), —COOH, —(CH 2 ) 1-3 COOR, or OR a (R a and R b each represents hydrogen, C 1-6 alkyl, or C 1-6 acyl); R 7 represents hydrogen, C 1-6 alkyl, —OR, or halogen; R 8 represents hydrogen, C 1-6 alkyl, hydroxyl, amino, or nitro; and R represents hydrogen or C 1-6 alkyl; or a salt thereof.
    一种用于预防或治疗皮肤真菌病的指甲或皮肤贴片,包含一个层,其中包括一个压敏粘合剂层和一个由以下式表示的化合物: 其中R 1 代表氢、C 1-16 烷基或三氟甲基;R 2 代表氢、C 1-6 烷基、卤素、—COO(C 1-6 烷基)或(CH 2 ) 1-3 COOR;R 3 代表氢、C 1-6 烷基、氨基、三氟甲基或OR;R 4 代表羟基;R 5 代表氢、C 1-6 烷基、羟基或卤素;R 6 代表氢、C 1-6 烷基、三氟甲基、卤素、氨基、—NR a R b 、硝基、羟基-C 1-6 烷基、—CONR a R b 、—COO(C 1-6 烷基)、—COOH、—(CH 2 ) 1-3 COOR或OR a (R a 和R b 各自代表氢、C 1-6 烷基或C 1-6 酰基);R 7 代表氢、C 1-6 烷基、—OR或卤素;R 8 代表氢、C 1-6 烷基、羟基、氨基或硝基;R代表氢或C 1-6 烷基;或其盐。
  • TOPICAL LIQUID AGENT FOR THE TREATMENT OF DERMATOPHYTOSIS
    申请人:MEIJI SEIKA PHARMA CO., LTD.
    公开号:US20140030209A1
    公开(公告)日:2014-01-30
    A topical liquid agent for a nail and/or skin for prevention or treatment of dermatophytosis comprises a film-forming agent and a compound represented by the formula: wherein R 1 represents hydrogen, C 1-6 alkyl, or trifluoromethyl, R 2 represents hydrogen, C 1-6 alkyl, halogen, —COO(C 1-6 alkyl), or (CH 2 ) 1-3 COOR where R represents hydrogen or C 1-6 alkyl, R 3 represents hydrogen, C 1-6 alkyl, amino, trifluoromethyl, or OR where R represents hydrogen or C 1-6 alkyl, R 4 represents hydroxyl, R 5 represents hydrogen, C 1-6 alkyl, hydroxyl, or halogen, R 6 represents hydrogen, C 1-6 alkyl, trifluoromethyl, halogen, amino, —NR a R b , nitro, hydroxy-C 1-6 alkyl, —CONR a R b , —COO(C 1-6 alkyl), —COOH, —(CH 2 ) 1-3 COOR, or OR a where R represents hydrogen or C 1-6 alkyl, R a and R b each represent hydrogen, C 1-6 alkyl, or C 1-6 acyl, R 7 represents hydrogen, C 1-6 alkyl, —OR where R represents hydrogen or C 1-6 alkyl, or halogen, R 8 represents hydrogen, C 1-6 alkyl, hydroxyl, amino, or nitro, or a salt thereof.
    一种用于预防或治疗真菌感染的指甲和/或皮肤的局部液体剂包括一种成膜剂和一个表示为以下结构式的化合物:其中R1代表氢、C1-6烷基或三氟甲基,R2代表氢、C1-6烷基、卤素、—COO(C1-6烷基)或(CH2)1-3COOR,其中R代表氢或C1-6烷基,R3代表氢、C1-6烷基、氨基、三氟甲基或OR,其中R代表氢或C1-6烷基,R4代表羟基,R5代表氢、C1-6烷基、羟基或卤素,R6代表氢、C1-6烷基、三氟甲基、卤素、氨基、—NRaRb、硝基、羟基-C1-6烷基、—CONRaRb、—COO(C1-6烷基)、—COOH、—(CH2)1-3COOR或ORa,其中R代表氢或C1-6烷基,Ra和Rb分别代表氢、C1-6烷基或C1-6酰基,R7代表氢、C1-6烷基、—OR(其中R代表氢或C1-6烷基)或卤素,R8代表氢、C1-6烷基、羟基、氨基或硝基,或其盐。
  • Synthesis, Opioid Receptor Binding, and Bioassay of Naltrindole Analogues Substituted in the Indolic Benzene Moiety
    作者:Subramaniam Ananthan、Cheryl A. Johnson、Ronald L. Carter、Sarah D. Clayton、Kenner C. Rice、Heng Xu、Peg Davis、Frank Porreca、Richard B. Rothman
    DOI:10.1021/jm980083i
    日期:1998.7.1
    assays in rat or guinea pig brain membranes and for their opioid antagonist and agonist activities in vitro on the guinea pig ileum (GPI) and mouse vas deferens (MVD) preparations. All of the compounds displayed delta selectivity in binding to the delta, mu, and kappa opioid receptors. The binding potencies of most of the compounds at the delta, mu, and kappa sites, however, were lower than that of 1. Among
    δ阿片受体拮抗剂纳曲酮(1)的一系列类似物,在4'-,5'-,6'-或-7'-位置(4-15)和一个通过纳曲酮的Fischer吲哚化反应,在吲哚苯环的5'-位(16)处的2-(2-吡啶基)乙烯基被合成。在大鼠或豚鼠脑膜中的阿片样物质受体结合试验中评估了化合物4-16的亲和力,以及在体外对豚鼠回肠(GPI)和小鼠输精管(MVD)制剂的阿片类拮抗剂和激动剂活性。所有化合物在结合δ,μ和κ阿片受体上均表现出δ选择性。但是,大多数化合物在δ,mu和kappa位的结合力都低于1。通常,7'-取代的化合物比6'-,5'-或4'-取代的类似物具有更高的亲和力,这表明在7'-位置比其他位置对大基团的耐受性更好。为了确定亚型选择剂,还确定了δ和kappa受体的假定亚型的化合物的亲和力:deltacx-1(mu-like),deltacx-2(delta-like)和kappa2b位点。尽管没有发现,但数据显
  • Topical antifungal agent
    申请人:Ohyama Makoto
    公开号:US08889727B2
    公开(公告)日:2014-11-18
    An anti-fungal agent for tinea comprising as active ingredient a compound having the skeleton of 2-(1H-pyrazol-1-yl)phenol represented by the following formula (I) or (II) or a salt thereof is provided
    提供一种治疗癣病的抗真菌剂,其活性成分为具有以下式(I)或(II)所表示的2-(1H-吡唑-1-基)苯酚骨架的化合物或其盐。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐